Impact of Immunohistochemical <scp>PSA</scp> and Ki‐67 Expression on Prognosis in Metastatic Castration‐Sensitive Prostate Cancer

20260 citationsJournal Article

Authors

Miyaka Umemori · Juntendo University

Fumihiko Urabe · Jikei University School of Medicine

Yuya Iwamoto · Jikei University School of Medicine

Yu Imai · Jikei University School of Medicine

Kojiro Tashiro · Jikei University School of Medicine

Shun Sato · Jikei University School of Medicine

Hiroyuki Takahashi

Abstract

Immunohistochemical PSA and Ki-67 expression provide practical prognostic information for patients with metastatic castration-sensitive prostate cancer. Combined assessment with EOD ≥ 3 identifies a high-risk subgroup with unfavorable clinical outcomes.

Topics & Keywords

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Radiopharmaceutical Chemistry and Applications

Publication Details

Published in: International Journal of Urology

Volume 33, Issue 2, pp. e70368-e70368

DOI: 10.1111/iju.70368

Field-Weighted Citation Impact: 0.00

Command Palette

Impact of Immunohistochemical <scp>PSA</scp> and Ki‐67 Expression on Prognosis in Metastatic Castration‐Sensitive Prostate Cancer

Authors

Abstract

Topics & Keywords

Publication Details